From startups to legacy brands, you're making your mark. We're here to help.
Key Links
Prepare for future growth with customized loan services, succession planning and capital for business equipment.
Key Links
Serving the world's largest corporate clients and institutional investors, we support the entire investment cycle with market-leading research, analytics, execution and investor services.
Key Links
Providing investment banking solutions, including mergers and acquisitions, capital raising and risk management, for a broad range of corporations, institutions and governments.
Your partner for commerce, receivables, cross-currency, working capital, blockchain, liquidity and more.
Key Links
A uniquely elevated private banking experience shaped around you.
Whether you want to invest on your own or work with an advisor to design a personalized investment strategy, we have opportunities for every investor.
For Companies and Institutions
From startups to legacy brands, you're making your mark. We're here to help.
Serving the world's largest corporate clients and institutional investors, we support the entire investment cycle with market-leading research, analytics, execution and investor services.
Your partner for commerce, receivables, cross-currency, working capital, blockchain, liquidity and more.
Prepare for future growth with customized loan services, succession planning and capital for business equipment.
Providing investment banking solutions, including mergers and acquisitions, capital raising and risk management, for a broad range of corporations, institutions and governments.
For Individuals
A uniquely elevated private banking experience shaped around you.
Whether you want to invest on you own or work with an advisor to design a personalized investment strategy, we have opportunities for every investor.
Explore a variety of insights.
Key Links
Insights by Topic
Explore a variety of insights organized by different topics.
Key Links
Insights by Type
Explore a variety of insights organized by different types of content and media.
Key Links
We aim to be the most respected financial services firm in the world, serving corporations and individuals in more than 100 countries.
Key Links
[calming music]
On screen:
This video opens with a logo over black:
Logo:
'J.P.Morgan.'
On screen:
Another logo appears:
Logo:
'Element Biosciences.'
On screen:
A woman with dark hair wears a black dress with red and white accents as she speaks from a bright office. Identifying text appears:
Text on screen:
'Molly He, Co-Founder and CEO, Element Biosciences.'
Molly He:
My name is Molly He, I'm a Co-Founder and CEO of Element Biosciences.
On screen:
A photo shows Ms. He sitting with two others under an Element Biosciences sign backed by greenery.
Molly He:
What Element Biosciences is, that's a big question.
On screen:
A lab technician opens a chamber, and vapor rises like smoke. Other members of the lab staff work on computers and fill test tubes.
Molly He:
The goal is to create a revolutionary sequencing platform to increase the access of sequencing around the world.
On screen:
The lab techs wear white coats and use high-tech equipment as they work. Then, a photo shows members of the founding team standing in front of a whiteboard.
Molly He:
It all started out almost seven years ago. Three of the co-founders, just scientists coming together and dreaming about making a huge impact in scientific tools.
On screen:
The founders smile behind computer monitors and pose for a picture beside a sign with a quote: 'Opening the world of biology to new possibilities...'
Molly He:
I do think that at the beginning of a business, if you want to be successful, you need to be with the right people. And that's really, really important; it's not just building the team, the right team, but also the right investors, right board members, and right banking partners.
On screen:
The team takes a picture at a construction site, with the scaffolding of the future Element Biosciences building rising behind them. Then, a woman with blonde hair in a cream blazer speaks from an office:
Text on screen:
'Elizabeth Weikes, Managing Director, J.P.Morgan.'
Elizabeth Weikes:
I think every founder will understand: We have tremendous resources and the connections that we can make at the firm.
On screen:
A team meets in a sunny conference room, then Ms. He stands at an outdoor podium as she addresses a crowd.
Elizabeth Weikes:
No matter what stage a company is in, whether it's early stage, mid, later-stage company, we deliver for the client. From the banking perspective, from the cash management perspective for their employees, from the 401(k) perspective, for planning from the executive side. Every single thing that anybody at the company has needed delivered, we have been able to do so.
On screen:
Ms. He consults with a lab technician, and the staff takes a photo on a grassy lawn. Ms. He smiles with the other founders.
Molly He:
Looking back, [I] didn't really anticipate we'll be here today. Seven years later, raised more than $400 million and actually launched a commercial product.
On screen:
She smiles as she walks along the office balcony.
Molly He:
But we have a really strong team of 320 consistently pushing the boundary of innovation.
On screen:
A photo shows the whole team outside the office. The video ends with a logo over white:
Logo:
'J.P.Morgan.'
Text on screen:
'Let's build your future together. jpmorgan.com/innovationeconomy.'
Side note:
Legal disclaimers:
Text on screen:
Copyright 2024 JPMorgan Chase & Co. All rights reserved. JPMorgan Chase Bank, N.A. Member FDIC. Deposits held in non-U.S. branches are not FDIC insured. Non-deposit products are not FDIC insured. Visit jpmorgan.com/cb-disclaimer for disclosures and disclaimers related to this content.'
END
In 2017, three passionate scientists—Molly He, Michael Previte, and Matthew Kellinger—came together because they had a dream to democratize access to genomic sequencing and advanced biological tools.
That dream wasn’t easy to realize at first.
“I grew up in China and there is a saying about newborn calves who are not afraid of tigers,” said Molly He, CEO and co-founder of Element Biosciences. “In retrospect, we felt like the newborn calves, a bit naive on how difficult it is to build a company. But we didn’t shy away from it.”
The group’s drive and fearlessness paid off. By June 2019, Element Biosciences completed Series A financing. Less than a year later, the startup had Series B financing. And by June 2021, it would close a $276 million Series C financing, helping them deliver on their promise of increasing access to affordable, high-quality genomic sequencing.
In 2022, Element Biosciences launched its first product, the AVITI™, a DNA benchtop sequencing platform powered by avidite base chemistry (ABC), which increased access to genomic sequencing in labs all over the world.
The AVITI platform allows a range of industries—from academia to biotech, cancer research and agriculture—to conduct sophisticated genomic research in-house, reducing dependence on external sequencing facilities and speeding up research, collaboration and scientific discoveries.
Over the past seven years, the company grew from three employees to 320. Molly attributes part of this success to what she calls a first-principles approach.
“When we start to build a company we often lean on experiences from the past,” Molly said. “That’s good, but you can often be restricted by those past experiences if you're keeping them front and center in a new situation. If you're going to create the next iteration of an industry, you need to come at this process from the perspective of 'New.' It’s important to build everything from the ground up.”
By adopting this method, one can think outside the box, Molly said. It’s also the basis for the company’s identity.
“The name ‘Element’ came out of the idea that we wanted to do everything with the first-principles basis, and create all these technical elements from the ground up,” Molly said.
“What’s so interesting about Molly and Element Biosciences is that Molly is a scientist by background,” said Elizabeth Weikes, a managing director at J.P. Morgan Wealth Management. “It’s very rare that you have a scientist CEO, let alone a female scientist CEO. In one of the first meetings I had with Molly, we really connected as women in the workplace.”
Molly said those shared values and experiences encouraged her to think more deeply about her role as a female founder in the life sciences sector.
“To be honest, I never thought I had the benefit of being a female founder until I started to interact with J.P. Morgan. That struck me as an epiphany, that I do have something to offer society, and it came from a conversation I had with people at J.P. Morgan.”
—Molly He, CEO and Co-Founder of Element Biosciences
In 2024, Element Biosciences raised more than $277 million in Series D funding to continue its work.
The company, Molly said, is creating a culture of continued learning and is focused on finding people who are never satisfied with the status quo.
“We have a saying in the company. It’s ‘Always be learning. Always be growing,’” said Molly. “We have a really strong team consistently pushing the boundary of innovation.”
The future of the company has been on Molly’s mind since day one. When Element Biosciences started, the company’s founders knew it wasn’t going to be limited to DNA sequencing. As the technology develops, the equipment can help customers study the molecular components that form and act upon DNA.
“DNA is one piece of the puzzle, but there are proteins, epigenetics and all the different things that come together,” Molly said. “When we made the innovation, we already thought ahead to looking at the proteins. We built these instruments to be future-proof.”
With decades of global experience, a robust professional and venture capital network, and scalable money-management solutions, J.P. Morgan offers many solutions for startups of all sizes. Visit our Innovation Economy page to learn more.
JPMorgan Chase Bank, N.A. Member FDIC. Visit jpmorgan.com/commercial-banking/legal-disclaimer for disclosures and disclaimers related to this content.
Banking
Powering investments in emerging geothermal technologies
Nov 26, 2024
Rapidly growing private sector demand for clean electricity is setting off a new race for innovative solutions.
Banking
A triple crown victory for JPMorganChase
Nov 21, 2024
The firm was recognized as the World’s Best Bank, the World’s Best Investment Bank and the World’s Best Private Bank by Global Finance magazine.
Banking
Financing a more sustainable future for El Salvador’s Lempa River
Nov 19, 2024
J.P Morgan played an integral role in the world’s largest debt-for-nature transaction aimed at supporting river conservation.
Banking
Wired for success: Closinglock has the keys to secure transactions
Nov 15, 2024
How Closinglock taps J.P. Morgan technology to bring peace of mind to the stressful last step in homebuying.
Banking
Nov 12, 2024
Our Applied Tech Report highlights applied tech industry trends, including sector snapshots into defense technology, AI, semiconductors, space technology and more.
Banking
Top takeaways from the 2024 Healthcare Advisory Council
Nov 08, 2024
Healthcare leaders gathered at J.P. Morgan’s 12th annual Healthcare Advisory Council to explore top trends like AI, cybersecurity, healthcare sectors ripe for disruption and more.
Banking
J.P. Morgan helps EchoStar set path for wireless future
Nov 01, 2024
The firm supported EchoStar in the sale of its satellite television business to DirecTV — a transaction that’s set to reshape the landscape of video distribution and wireless services in the United States.
Banking
Hyundai drives forward with a record $3.3 billion IPO in India
Oct 31, 2024
Investors eye long-term potential in the Korean carmaker’s India debut, the nation’s largest IPO in history.
You're now leaving J.P. Morgan
J.P. Morgan’s website and/or mobile terms, privacy and security policies don’t apply to the site or app you're about to visit. Please review its terms, privacy and security policies to see how they apply to you. J.P. Morgan isn’t responsible for (and doesn’t provide) any products, services or content at this third-party site or app, except for products and services that explicitly carry the J.P. Morgan name.